Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1- accumulation

Blood

Volumn 89, Issue 8, 1997, Pages 2938-2950

  Bergh, Gösta ^a,b   Ehingen, Mats ^a   Olofsson, Tor ^a   Baldetorp, Bo ^a   Johnsson, Ellinor ^a   Brycke, Helena ^a   Lindgren, Gustaf ^a   Olsson, Inge ^a   Gullberg, Urban ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCITRIOL; DNA; HEMIN; HEMOGLOBIN; MEMBRANE ANTIGEN; RETINOBLASTOMA PROTEIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; ERYTHROID CELL; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL LINE; MONOCYTE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030982906     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2938     Document Type: Article

References (62)

1. Benedict WF, Murprhee AL, Banerjee A, Spina CA, Sparkes MC, Sparkes RS: Patient with 13 chromosome deletion: Evidence that the retinoblastoma gene is a recessive cancer gene. Science 219:973, 1983
2. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643, 1986
3. Lee EY, To H, Shew JY, Bookstein R, Scully P, Lee WH: Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241:218, 1988
4. Reissman PT, Simon MA, Lee WH, Slamon DJ: Studies of the retinoblastoma gene in human sarcomas. Oncogene 4:839, 1989
5. Weinberg RA: Tumor suppressor genes. Science 254:1138, 1991
6. Huang HJ, Yee JK, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EY, Lee WH: Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563, 1988
7. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712, 1990
8. Qin XQ, Chittenden T, Livingston DM, Kaelin WG: Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6:653, 1992
9. Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY: The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding capacity. Nature 329:642, 1987
10. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323, 1995
11. Chen PL, Scully P, Shew JY, Wang JY, Lee WH: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193, 1989
12. Buchkovich K, Duffy LA, Harlow E: The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097, 1989
13. De Caprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingston DM: The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085, 1989
14. Hollingsworth RE, Hensey CE, Lee WH: Retinoblastoma protein and the cell cycle. Curr Opin Genet Dev 3:55, 1993
15. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR: The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053, 1991
16. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR: The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177, 1992
17. Johnson LF: G1 events and the regulation of genes for S-phase enzymes. Curr Opin Cell Biol 4:149, 1992
18. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K: The retinoblastoma protein binds to family of E2F transcription factors. Mol Cell Biol 13:7813, 1993
19. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH: The retinoblastoma gene product regulates progression through the G1-phase of the cell cycle. Cell 67:293, 1991
20. Nevins JR: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424, 1992
21. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR: Adenovirus E1A, simian virus 40 tumor antigen, and human papilloma virus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 89:4549, 1992
22. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for Rb are nonviable and show defects in neurogenesis and hematopoiesis. Nature 359:288, 1992
23. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H: Requirement for a functional Rb-1 gene in murine development. Nature 359:328, 1992
24. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 359:295, 1992
25. Lee EY, Hu N, Yuan SS, Cox LA, Bradley A, Lee WH, Herrup K: Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 8:2008, 1994
26. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72, 1994
27. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B: Interaction of myogenic factors and the retinpblastoma-protein mediates muscle cell commitment and differentiation. Cell 72:309, 1993
28. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal Ginard B: Reversal of the terminal differentiation mediated by p107 in Rb-/-muscle cells. Science 264:1467, 1994
29. Furukawa Y, De Caprio JA, Freedman A, Kanakura Y, Nakamura M, Ernst TJ, Livingston DM, Griffin JD: Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc Natl Acad Sci USA 87:2770, 1990
30. Condorelli GL, Testa U, Valtieri M, Vitelli L, De Luca A, Barberi T, Montesoro E, Campisi S, Giordano A, Peschle C: Modulation of retinoblastoma gene in normal adult hematopoiesis: Peak expression and functional role in advanced erythroid differentiation. Proc Natl Acad Sci USA 92:4808, 1995
31. Nichols J, Nimer SD: Transcription factors, translocations and leukemia. Blood 80:2953, 1992
32. Ahuja HG, Jat PS, Foti A, Bar-Eli M, Cline MJ: Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukaemia. Blood 78:3259, 1991
33. Towatari M, Adachi K, Kato H, Saito H: Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood 78:2178, 1991
34. Tang JL, Yeh SH, Chen PJ, Lin MT, Tien HF, Chen YC: Inactivation of the retinoblastoma gene in acute myelogenous leukemia. Br J Haematol 82:502, 1992
35. Zhu YM, Bradbury D, Russel N: Decreased retinoblastoma protein expression in acute myeloblastic leukaemia is associated with the autonomous proliferation of clonogenic blasts. Br J Haematol 86:533, 1994
36. Kornblau SM, Xu HJ, Zhang W, Hu SX, Beran M, Smith TL, Hester J, Estey E, Benedict WF, Deisseroth AB: Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 84:256, 1994
37. Sundström C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U 937). Int J Cancer 17:565, 1976
38. Olsson I, Breitman TR: Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′:5′-monophosphate inducing agents. Cancer Res 42:3924, 1982
39. Olsson I, Gullberg U, Ivhed I, Nilsson K: Induction of the human histiocytic lymphoma cell line U-937 by 1 alfa, 25-dihydroxycholecalciferol. Cancer Res 43:5862, 1983
40. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321, 1975
41. Chen LL, Dean A, Jenkinson T, Mendelsohn T: Effect of transforming growth factor-β1 on proliferation and induction of hemoglobin accumulation in K562 cells. Blood 74:2368, 1989
42. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocyte leukemia. Blood 72:567, 1988
43. Ehinger M, Nilssson E, Persson A-M, Olsson I, Gullberg U: Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562. Cell Growth Differ 6:9, 1995
44. Baldetorp B, Dahlberg M, Holst U, Lindgren G: Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry 10:695, 1989
45. Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Åkerman M, Killander D: Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry 13:577, 1992
46. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD 14, a receptor for complexes of lipopolysacharides (LPS) and LPS binding proteins. Science 249:1431, 1990
47. Öberg F, Botling J, Nilsson K: Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD 14 and CD 23 expression during monocytic differentiation of U-937 cells. J Immunol 150:3487, 1993
48. Carlos TM, Marian JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068, 1994.
49. Koike M, Ishino K, Ikuta T, Huh N, Kuroki T: Growth enhancement of normal human keratinocytes by the antisense oligonucleotide of retinoblastoma susceptibility gene. Oncogene 10:117, 1995
50. Sczakiel G: Antisense stratagies for the control of aberrant gene expression. J Hematother 3:305, 1994
51. Endo T, Goto S: Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen. J Biochem 112:427, 1992
52. Szekely L, Jiang WQ, Bulic-Jakus F, Rosen A, Ringertz N, Klein G, Wiman KG: Cell type and differentiation dependent heterogenity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Diff 3:149, 1992
53. Slack RS, Hamel PA, Bladoin TS, Gill RM, Mc Burney MW: Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells, Oncogene 8:1585, 1993
54. Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albert DM, Windle JJ: Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the prescence or absence of p53. Genes Dev 8:1300, 1994
55. Ehinger M, Bergh G, Olofsson T, Baldetorp B, Olsson I, Gullberg U: Expression of the p53 tumor suppressor gene induces differentiation and promotes induction of differentiation by 1,25 dihydroxycholecalciferol in leukemic U937 cells. Blood 87:1064, 1996
56. Pardee AB: G1 events and regulation of cell proliferation. Science 246:603, 1989
57. 57: Chen PL, Riley DJ, Chen-Kiang S, Lee WH: Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci USA 93:465, 1996
58. Schwarz JK, Devoto SH, Smith EJ, Chellappan SP, Jakoi L, Nevins JR: Interactions of the p107 and Rb proteins with E2F during the cell proliferatipn response. EMBO J 12:1013, 1993
59. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E: Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7:1111, 1993
60. Carrol M, Zhu Y, D'Andrea AD: Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle. Proc Natl Acad Sci USA 92:2869, 1995
61. Zhuo S, Fan S, Huang S, Kaufman S: Study of the role of retinoblastoma protein in terminal differentation of murine erythroleukemia cells. Proc Natl Acad Sci USA 92:4234, 1995
62. Welch PJ, Wang JYJ: Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev 9:31, 1995